# Provider Protocol Plan (PROVIDER-ONLY)

_Provider-entered/edited plan. Not patient-facing instructions, a diagnosis, or autonomously generated dosing. Dosing references are source-attributed and provider-reviewed material only._

**Title:** Test
**Patient:** TEST-THOMAS-COURT
**Provider:** dashboard
**Status:** draft

## Components (8)

### 1. BPC-157

### 2. GHK-Cu (primary)
- Rationale: Applied from template "Klow Stack (peptidedosingprotocols.com)" v1. Provider review required before sign-off.
- Provider instruction: [From template] Dose: 50 mg; Route: subcutaneous; Frequency: once daily; Duration: 4-6 weeks; Cycle: 4-6 weeks on, 2-4 weeks off; Reconstitution: Add 3.0 mL bacteriostatic water to the 80 mg vial.
- Safety: Provider override: From Peptide Dosing Protocols stack reference (https://www.peptidedosingprotocols.com/stacks/klow-stack). Secondary source — confirm before clinical use.

### 3. Semax (primary)
- Rationale: Applied from template "Neurorecovery Template v1" v1.0.0. Provider review required before sign-off.
- Provider instruction: [From template] Dose: 300-600 mcg intranasally daily (or 1-3 drops/nostril of 0.1% solution); Route: intranasal; Frequency: once or twice daily; Duration: 10-14 day cycles; Cycle: Repeat cycles per provider direction; Reconstitution: Compounded intranasal solution - no reconstitution required
- Monitoring: Cognition, mood
- Dosing reference (provider-reviewed): 300-600 mcg intranasally daily (or 1-3 drops/nostril of 0.1% solution)
  - Source: Practitioner Peptide Dosing Reference (commonly published ranges) — Compiled practitioner reference (internal_protocol)

### 4. KPV (support)
- Rationale: Applied from template "Klow Stack (peptidedosingprotocols.com)" v1. Provider review required before sign-off.
- Provider instruction: [From template] Dose: 10 mg; Route: subcutaneous; Frequency: once daily; Duration: 4-6 weeks; Cycle: 4-6 weeks on, 2-4 weeks off; Reconstitution: Add 3.0 mL bacteriostatic water to the 80 mg vial.
- Safety: Provider override: From Peptide Dosing Protocols stack reference (https://www.peptidedosingprotocols.com/stacks/klow-stack). Secondary source — confirm before clinical use.

### 5. Selank (support)
- Rationale: Applied from template "Neurorecovery Template v1" v1.0.0. Provider review required before sign-off.
- Provider instruction: [From template] Dose: 250-500 mcg intranasally daily (or 0.15% solution per protocol); Route: intranasal; Frequency: once or twice daily; Duration: 10-14 day cycles; Cycle: Repeat cycles per provider direction; Reconstitution: Compounded intranasal solution - no reconstitution required
- Monitoring: Anxiety, sleep
- Dosing reference (provider-reviewed): 250-500 mcg intranasally daily (or 0.15% solution per protocol)
  - Source: Practitioner Peptide Dosing Reference (commonly published ranges) — Compiled practitioner reference (internal_protocol)

### 6. BPC-157 (support)
- Rationale: Applied from template "Klow Stack (peptidedosingprotocols.com)" v1. Provider review required before sign-off.
- Provider instruction: [From template] Dose: 10 mg; Route: subcutaneous; Frequency: once daily; Duration: 4-6 weeks; Cycle: 4-6 weeks on, 2-4 weeks off; Reconstitution: Add 3.0 mL bacteriostatic water to the 80 mg vial.
- Safety: Provider override: From Peptide Dosing Protocols stack reference (https://www.peptidedosingprotocols.com/stacks/klow-stack). Secondary source — confirm before clinical use.

### 7. P21 (optional)
- Rationale: Applied from template "Neurorecovery Template v1" v1.0.0. Provider review required before sign-off.
- Provider instruction: [From template] Dose: Practitioner ranges vary; commonly ~1 mg SC daily - provider-directed; Route: subcutaneous; Frequency: once daily; Duration: Per provider direction; Cycle: Per provider direction; Reconstitution: Reconstitute with bacteriostatic water
- Monitoring: Cognition
- Dosing reference (provider-reviewed): Practitioner ranges vary; commonly ~1 mg SC daily - provider-directed
  - Source: Practitioner Peptide Dosing Reference (commonly published ranges) — Compiled practitioner reference (internal_protocol)

### 8. TB-500 / TB4 (support)
- Rationale: Applied from template "Klow Stack (peptidedosingprotocols.com)" v1. Provider review required before sign-off.
- Provider instruction: [From template] Dose: 10 mg; Route: subcutaneous; Frequency: once daily; Duration: 4-6 weeks; Cycle: 4-6 weeks on, 2-4 weeks off; Reconstitution: Add 3.0 mL bacteriostatic water to the 80 mg vial.
- Safety: Provider override: From Peptide Dosing Protocols stack reference (https://www.peptidedosingprotocols.com/stacks/klow-stack). Secondary source — confirm before clinical use.

_Provider-only. Patient-facing care plan output is a separate, future provider-approved step._